BRCA1/BRCA2 Panel
Comprehensive BRCA1 and BRCA2 gene analysis for hereditary breast and ovarian cancer risk.
Genetics, made clearer
GGC DNA connects patients, clinicians, and research teams to trusted genetic testing with practical guidance at every step—from test selection to sample collection and interpretation.
A guided starting point
Start with what matters
Browse the catalog by specialty, then connect with a counselor when you need a second opinion on the next step.
0 tests to explore
Explore0 tests to explore
Explore0 tests to explore
Explore0 tests to explore
Explore1 tests to explore
Explore2 tests to explore
ExploreFeatured in the catalog
Each test is presented with practical details so clinicians and families can make informed next decisions.
Comprehensive BRCA1 and BRCA2 gene analysis for hereditary breast and ovarian cancer risk.
Screening for 100+ autosomal and X-linked recessive conditions.
Non-invasive prenatal screening for common trisomies.
Analysis of 50+ pharmacogenes for drug metabolism.
Built for distance
From New Mexico to Kenya and beyond, our network helps make collection and coordination easier for patients, providers, and partner laboratories.
Find collection supportCoordinated logistics for samples and specialist communication across borders.
Local collection guidance and practical support for patients and partners in Kenya.
Clear communication from test selection to collection, with a team that understands clinical and operational realities.
For hospitals, labs, and universities
GGC DNA works with hospitals, sample collection centers, clinicians, students, research scholars, and universities looking for a reliable genetics partner.
Collaboration pathways
Our laboratory
GGC DNA is part of a research-minded laboratory ecosystem serving patients and partners around the world.
Transparency matters
Our website is designed to help you understand options and ask better questions. Results and medical decisions should always be reviewed with a qualified healthcare professional.
Medical education
Pharmacogenomic testing helps doctors prescribe the right medication at the right dose based on your genetic makeup.
Read articleNon-invasive prenatal testing (NIPT) analyzes cell-free fetal DNA in maternal blood to screen for chromosomal conditions.
Read articleBRCA1 and BRCA2 gene mutations significantly increase cancer risk. Learn about testing, implications, and prevention strategies.
Read articleYour next step can be simple
Start with the catalog or speak with our team about the right path for your patient, family, or research program.